PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS Jan 12, 2022
atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R-ketamine Program Jan 12, 2022